Researchers at Fox Chase Cancer Center demonstrated how amplification and rearrangement of a gene associated with leukemia, known as MLL, is directly controlled by epigenetic factors, providing needed insights into a new therapeutic opportunity.
Lorenzo Galluzzi was named associate professor with tenure in the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center.
